JEFFREY J LEE

Allopathic & Osteopathic Physicians|Internal Medicine BRONX, NY NPI 1023101243

General Payments — all program years on this page

$4,084.61

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 158
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $483.82 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $483.8218

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $418.6815
Acerta Pharma LLC $38.522
Smith & Nephew, Inc. $26.621

By program year

Program yearAmountRecords
2018 $318.1910
2019 $783.7615
2020 $439.3518
2021 $841.3238
2022 $789.7740
2023 $428.4019
2024 $483.8218

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096592502 Novo Nordisk Inc $7.28 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096807724 Novo Nordisk Inc $18.42 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096860056 Novo Nordisk Inc $21.66 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096884154 Novo Nordisk Inc $23.30 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096925194 Novo Nordisk Inc $125.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096927792 Novo Nordisk Inc $22.76 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096943040 Novo Nordisk Inc $23.10 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097082133 Novo Nordisk Inc $18.34 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097180087 Novo Nordisk Inc $23.95 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097271881 Novo Nordisk Inc $20.96 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097630886 Novo Nordisk Inc $31.27 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097710112 Novo Nordisk Inc $14.07 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097724455 Novo Nordisk Inc $23.30 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097740604 Novo Nordisk Inc $22.15 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097799807 Novo Nordisk Inc $23.12 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104311738 AstraZeneca Pharmaceuticals LP $20.64 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105637522 AstraZeneca Pharmaceuticals LP $17.88 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149598148 Smith+Nephew, Inc. $26.62 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.